✦ LIBER ✦

Phase II Trial of Alternating mFOLFOX6 and FOLFIRI Regimens in the First-Line Treatment for Unresectable or Metastatic Colorectal Cancer (KSCC0701)

✍ Scribed by Oki, Eiji; Emi, Yasunori; Akagi, Yoshito; Tokunaga, Shoji; Sadanaga, Noriaki; Tanaka, Takaho; Ogata, Yutaka; Saeki, Hiroshi; Kakeji, Yoshihiro; Baba, Hideo; Nishimaki, Tadashi; Natsugoe, Shoji; Shirouzu, Kazuo; Maehara, Yoshihiko

Book ID: 120070585
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 150 KB
Volume: 84
Category: Article
ISSN: 0030-2414
DOI: 10.1159/000346690

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of FOLFOX6 and Cetuxima

A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer

✍ Ralph V. Boccia; Thomas M. Cosgriff; David L. Headley; Suprith Badarinath; Shake 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 410 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB

The efficacy and safety of bevacizumab b

The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)

✍ Goro Nakayama, Keisuke Uehara, Kiyoshi Ishigure… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 352 KB

A Randomized Phase II Trial of Three Int

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

✍ Ychou, Marc; Rivoire, Michel; Thezenas, Simon; Quenet, FranÃ§ois; Delpero, Jean- 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 367 KB

3060 POSTER Final data from a large phas

3060 POSTER Final data from a large phase II trial of first-line bevacizumab plus classic or modified FOLFIRI in metastatic colorectal cancer (CRC)

✍ A. Sobrero; S. Ackland; S. Clarke; R. Perez-Carrión; S. Chiara; J. Gapski; P. Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Commentary on a Phase III Trial of Bevac

Commentary on a Phase III Trial of Bevacizumab plus XELOX or FOLFOX4 for First-Line Treatment of Metastatic Colorectal Cancer: The NO16966 Trial

✍ Preeta Tyagi; Axel Grothey 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB